{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:07:58Z","timestamp":1793941678764,"version":"4.8.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["[2022]-7"],"award-info":[{"award-number":["[2022]-7"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023A03J0300"],"award-info":[{"award-number":["2023A03J0300"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023B01J1016"],"award-info":[{"award-number":["2023B01J1016"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.phymed.2026.158003","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:48:29Z","timestamp":1771832909000},"page":"158003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP\/ANKRD1 axis"],"prefix":"10.1016","volume":"155","author":[{"given":"Yi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-3947","authenticated-orcid":false,"given":"Zengjie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dailin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-6189","authenticated-orcid":false,"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158003_bib0001","series-title":"Understanding Quinones with Reference to Biochemistry, Quinones: A Privileged Moiety for Drug Discovery","first-page":"167","author":"Ali","year":"2025"},{"key":"10.1016\/j.phymed.2026.158003_bib0002","article-title":"Exploring the therapeutic potential of Baicalin against MCF-7 breast cancer cells: biochemical, In vitro, and computational perspectives","author":"Ali","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158003_bib0003","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2026.158003_bib0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2019.09.133","article-title":"Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization","volume":"520","author":"Chen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2026.158003_bib0005","doi-asserted-by":"crossref","DOI":"10.1177\/15347354221151147","article-title":"Yifei Sanjie formula or Placebo with Anlotinib as second-line or above treatment for metastatic non-small-cell lung cancer: study protocol for a double-blind, placebo-controlled randomized pilot study","volume":"22","author":"Chen","year":"2023","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.phymed.2026.158003_bib0006","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/mp3002792","article-title":"Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer","volume":"9","author":"Chitkara","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phymed.2026.158003_bib0007","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2026.158003_bib0008","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158003_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhazmat.2018.05.013","article-title":"GPER\/hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells","volume":"355","author":"Deng","year":"2018","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.phymed.2026.158003_bib0010","first-page":"279","article-title":"Interrelationships of Vero cytotoxin producing Escherichia coli infections of humans and animals","volume":"84","author":"Dorn","year":"1988","journal-title":"Acta Vet. Scand. Suppl."},{"key":"10.1016\/j.phymed.2026.158003_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112305","article-title":"Co-encapsulated nanoparticles of Erlotinib and Quercetin for targeting lung cancer through nuclear EGFR and PI3K\/AKT inhibition","volume":"211","author":"Ganthala","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.phymed.2026.158003_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113417","article-title":"Inhibiting G6PD by quercetin promotes degradation of EGFR T790M mutation","volume":"42","author":"Ge","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2026.158003_bib0013","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phymed.2026.158003_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.959938","article-title":"Myricetin activates the caspase-3\/GSDME pathway via ER stress induction of pyroptosis in lung cancer cells","volume":"13","author":"Han","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158003_bib0015","first-page":"543","article-title":"[Cellular receptors for animal viruses]","volume":"13","author":"Homma","year":"1968","journal-title":"Tanpakushitsu KakuSan Koso"},{"key":"10.1016\/j.phymed.2026.158003_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201516","article-title":"Targeted drug\/gene\/photodynamic therapy via a stimuli-responsive dendritic-polymer-based nanococktail for treatment of EGFR-TKI-resistant non-small-cell lung cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2026.158003_bib0017","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/cac2.12609","article-title":"Yap methylation-induced FGL1 expression suppresses anti-tumor immunity and promotes tumor progression in KRAS-driven lung adenocarcinoma","volume":"44","author":"Jiang","year":"2024","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.phymed.2026.158003_bib0018","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fphar.2019.00732","article-title":"Chinese herbal medicine combined with EGFR-TKI in EGFR mutation-positive advanced pulmonary adenocarcinoma (CATLA): a multicenter, randomized, double-blind, placebo-controlled trial","volume":"10","author":"Jiao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158003_bib0019","doi-asserted-by":"crossref","first-page":"88437","DOI":"10.18632\/oncotarget.18177","article-title":"The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth","volume":"8","author":"Jim\u00e9nez","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2026.158003_bib0020","first-page":"135","article-title":"[Cardiac arrhythmia and apical injury in chronic Chagas cardiopathy. Considerations on a case]","volume":"31","author":"Jorge","year":"1978","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.phymed.2026.158003_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153821","article-title":"He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1\/Rap1 signaling pathway","volume":"94","author":"Kan","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158003_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207588","article-title":"Atorvastatin augments gemcitabine-mediated anti-cancer effects by inhibiting yes-associated protein in Human cholangiocarcinoma cells","volume":"21","author":"Kitagawa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158003_bib0023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","article-title":"Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway","volume":"37","author":"Kurppa","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2026.158003_bib0024","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/onc.2013.566","article-title":"Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis","volume":"34","author":"Lei","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2026.158003_bib0025","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41419-022-05224-7","article-title":"P130cas-FAK interaction is essential for YAP-mediated radioresistance of non-small cell lung cancer","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phymed.2026.158003_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105574","article-title":"Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling","volume":"171","author":"Li","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2026.158003_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071362","article-title":"Ankyrin repeat domain 1 protein: a functionally pleiotropic protein with cardiac biomarker potential","volume":"18","author":"Ling","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158003_bib0028","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12935-024-03416-z","article-title":"Pitavastatin sensitizes the EGFR-TKI associated resistance in lung cancer by inhibiting YAP\/AKT\/BAD-BCL-2 pathway","volume":"24","author":"Liu","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.phymed.2026.158003_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154723","article-title":"Shenlingcao oral liquid for patients with non-small cell lung cancer receiving adjuvant chemotherapy after radical resection: a multicenter randomized controlled trial","volume":"113","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158003_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12935-021-02095-4","article-title":"MINDY1 promotes bladder cancer progression by stabilizing YAP","volume":"21","author":"Luo","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.phymed.2026.158003_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n2363","article-title":"Advances in systemic therapy for non-small cell lung cancer","author":"Miller","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2026.158003_bib0032","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1096\/fj.10-160291","article-title":"Loss of desmin triggers mechanosensitivity and up-regulation of Ankrd1 expression through Akt-NF-\u03bab signaling pathway in smooth muscle cells","volume":"26","author":"Mohamed","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.phymed.2026.158003_bib0033","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.phymed.2026.158003_bib0034","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.annonc.2020.06.017","article-title":"A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy","volume":"31","author":"Park","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2026.158003_bib0035","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ijbiomac.2020.03.066","article-title":"Fucoidan increased the sensitivity to gefitinib in lung cancer cells correlates with reduction of tgf\u03b2-mediated Slug expression","volume":"153","author":"Qiu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2026.158003_bib0036","first-page":"215","article-title":"[Ultrathin sections and high-resolution electron microscopy]","volume":"32","author":"Raska","year":"1983","journal-title":"Cesk. Fysiol."},{"key":"10.1016\/j.phymed.2026.158003_bib0037","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.phymed.2026.158003_bib0038","first-page":"1604","article-title":"Electrical activity of the cerebral cortex in epileptic patients during work therapy","volume":"68","author":"Rubinova","year":"1968","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.phymed.2026.158003_bib0039","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/0300985820948823","article-title":"Wnt\/\u03b2-catenin and hippo pathway deregulation in mammary tumors of humans, dogs, and cats","volume":"57","author":"Sammarco","year":"2020","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.phymed.2026.158003_bib0040","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1158\/1078-0432.CCR-07-5189","article-title":"Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer","volume":"14","author":"Scurr","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158003_bib0041","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2026.158003_bib0042","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2026.158003_bib0043","article-title":"Ankyrin repeat domain 1 overexpression is associated with common resistance to Afatinib and Osimertinib in EGFR-mutant","volume":"8","author":"Takahashi","year":"2018","journal-title":"Lung Cancer. Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158003_bib0044","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158003_bib0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41419-022-04781-1","article-title":"USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ","volume":"13","author":"Tang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phymed.2026.158003_bib0046","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7150\/ijbs.54194","article-title":"SOX13\/TRIM11\/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer","volume":"17","author":"Tang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158003_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154315","article-title":"Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: a systematic review and meta-analysis","volume":"104","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158003_bib0048","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13048-024-01385-5","article-title":"FTO attenuates the cytotoxicity of cisplatin in KGN granulosa cell-like tumour cells by regulating the Hippo\/YAP1 signalling pathway","volume":"17","author":"Wang","year":"2024","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.phymed.2026.158003_bib0049","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2026.158003_bib0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12964-023-01073-9","article-title":"ATXN3 promotes prostate cancer progression by stabilizing YAP","volume":"21","author":"Wu","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.phymed.2026.158003_bib0051","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-3701-5-7","article-title":"Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib","volume":"5","author":"Xu","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.phymed.2026.158003_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116566","article-title":"Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET\/EGFR signaling pathway","volume":"314","author":"Yang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158003_bib0053","article-title":"Deciphering the effects and mechanisms of Yi-Fei-San-Jie-pill on non-small cell lung cancer with integrating network target analysis and experimental validation","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158003_bib0054","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.arcmed.2021.08.004","article-title":"LncRNA RGMB-AS1 up-regulates ANKRD1 through competitively sponging miR-3614-5p to promote OSA cell proliferation and invasion","volume":"53","author":"Yin","year":"2022","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.phymed.2026.158003_bib0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS."},{"key":"10.1016\/j.phymed.2026.158003_bib0056","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/aps.2016.116","article-title":"Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2026.158003_bib0057","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-020-01202-9","article-title":"Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2026.158003_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106293","article-title":"Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking","volume":"151","author":"Zhang","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.phymed.2026.158003_bib0059","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1142\/S0192415X18500490","article-title":"Chinese Herbal medicine for advanced non-small-cell lung cancer: a systematic review and meta-analysis","volume":"46","author":"Zhang","year":"2018","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2026.158003_bib0060","first-page":"155","article-title":"Efficacy observation of modified Yiqi Chutan recipe treating mid-late stage NSCLC patients by CT perfusion","volume":"36","author":"Zheng","year":"2016","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.phymed.2026.158003_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118343","article-title":"Mechanistic insights into Yifei Sanjie pill's regulation of EMT to enhance gefitinib treatment effect in NSCLC by in silico analysis and experimental validation","volume":"334","author":"Zhou","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158003_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154491","article-title":"Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer","volume":"108","author":"Zhuang","year":"2023","journal-title":"Phytomedicine"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:59:58Z","timestamp":1790114398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326002400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"alternative-id":["S0944711326002400"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158003","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP\/ANKRD1 axis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158003"}}